Literature DB >> 3409122

Acute encephalopathy and third-nerve palsy after chymopapain injection.

B A Anderson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3409122      PMCID： PMC1268159     

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  6 in total

1.  Prevention of chymopapain anaphylaxis by screening chemonucleolysis candidates with cutaneous chymopapain testing. A preliminary report.

Authors:  L C Grammer; M Schafer; D Bernstein; I L Bernstein; J Dolovich; M Schatz; R Zeiger; F Cogen; J J Shaughnessy; M J Chandler
Journal:  Clin Orthop Relat Res       Date:  1987-08       Impact factor: 4.176

2.  The fate of chymopapain injected for therapy of intervertebral disc disease.

Authors:  A A Kapsalis; I J Stern; I Bornstein
Journal:  J Lab Clin Med       Date:  1974-04

3.  Tissue response to chymopapain in different concentrations. Animal investigations on microvascular effects.

Authors:  P I Brånemark; R Ekholm; J Lundskog
Journal:  Clin Orthop Relat Res       Date:  1969 Nov-Dec       Impact factor: 4.176

Review 4.  Update on chymopapain.

Authors:  C B Shields; E J Arpin
Journal:  Neurol Clin       Date:  1985-05       Impact factor: 3.806

5.  Chymodiactin in patients with herniated lumbar intervertebral disc(s). An open-label, multicenter study.

Authors:  D J McDermott; K Agre; M Brim; F J Demma; J Nelson; R R Wilson; R A Thisted
Journal:  Spine (Phila Pa 1976)       Date:  1985-04       Impact factor: 3.468

6.  Hemorrhagic complications after the lumbar injection of chymopapain.

Authors:  A Buchman; R B Wright; M D Wichter; W W Whisler; A Bosch
Journal:  Neurosurgery       Date:  1985-02       Impact factor: 4.654
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.